1/15
07:46 am
knsa
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating.
Low
Report
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating.
1/13
09:03 am
knsa
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) had its price target raised by analysts at Wedbush from $48.00 to $50.00. They now have an "outperform" rating on the stock.
Medium
Report
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) had its price target raised by analysts at Wedbush from $48.00 to $50.00. They now have an "outperform" rating on the stock.
1/12
07:30 am
knsa
Kiniksa Pharmaceuticals Provides Corporate Update
Medium
Report
Kiniksa Pharmaceuticals Provides Corporate Update
1/7
04:01 pm
knsa
Kiniksa Pharmaceuticals to Present at 44th Annual J.P. Morgan Healthcare Conference
Low
Report
Kiniksa Pharmaceuticals to Present at 44th Annual J.P. Morgan Healthcare Conference
12/2
07:33 pm
knsa
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $48.00 price target on the stock.
Low
Report
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $48.00 price target on the stock.
11/12
04:01 pm
knsa
Kiniksa Pharmaceuticals to Present at Jefferies Global Healthcare Conference in London
Low
Report
Kiniksa Pharmaceuticals to Present at Jefferies Global Healthcare Conference in London
11/2
01:15 am
knsa
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) was downgraded by analysts at
Low
Report
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) was downgraded by analysts at
Report
11/2
01:15 am
knsa
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) was downgraded by analysts at
Low
Report
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) was downgraded by analysts at
Report
10/29
02:28 pm
knsa
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $45.00 to $55.00. They now have a "buy" rating on the stock.
Low
Report
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $45.00 to $55.00. They now have a "buy" rating on the stock.
10/28
01:13 pm
knsa
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $48.00 price target on the stock, up previously from $44.00.
Low
Report
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $48.00 price target on the stock, up previously from $44.00.
10/28
07:30 am
knsa
Kiniksa Pharmaceuticals Reports Third Quarter 2025 Financial Results and Recent Portfolio Execution
Medium
Report
Kiniksa Pharmaceuticals Reports Third Quarter 2025 Financial Results and Recent Portfolio Execution
10/23
04:01 pm
knsa
Kiniksa Pharmaceuticals to Report Third Quarter 2025 Financial Results on October 28, 2025
Low
Report
Kiniksa Pharmaceuticals to Report Third Quarter 2025 Financial Results on October 28, 2025